David S. Burgess, PharmD, FCCP, FIDP
Dr. Burgess currently serves as Professor and Chair in the Department of Pharmacy Practice and Science at the University of Kentucky College of Pharmacy. He has helped shape our organization in numerous ways, including by serving on the Board as a Member-at-Large from 2005 to 2007 and as President-elect, President, and then Immediate Past President from 2009 to 2011. Over 23 years as an educator and mentor, he has reached every level of learner and created new opportunities for training along the way. He started the Infectious Disease Fellowship at the University of Texas and University of Texas Health Science Center in 1998, and then transitioned to create a MS program with an emphasis in infectious diseases. When he moved to the University of Kentucky, he initiated a joint PharmD/MS program and an MS/residency program with an emphasis in infectious diseases. He has authored over 65 peer-reviewed original research manuscripts, 8 review articles, and 5 book chapters. His research includes both clinical and in vitro analyses which directly impact antimicrobial stewardship and ID, particularly in the area of multidrug-resistant gram-negative bacterial infections.
Peggy Carver, PharmD, FCCP, FIDP
Dr. Carver currently serves as a tenured Associate Professor at the University of Michigan College of Pharmacy. She has an extensive record of service with SIDP, including serving as its first female president during her 3-year term from 1999-2002 and providing an impressive 25+ years of committee service to the organization. She has built a legacy of sustained, innovative clinical education, including computer-assisted review of microbiology and antimicrobial agents in the late 80's and early 90's. In 1987, she also developed a PGY2 ID residency at UM Hospital and has served on the local Residency Advisory Committee for over 25 years. In additional to providing core ID lectures at the college, she has delivered >200 continuing education lectures and >50 oral scientific research presentations and is widely respected for her expertise in antifungal pharmacotherapy. More recently, her research focus has shifted to an interest in the role of metal ions in infectious diseases, as demonstrated by her scholarly output which includes co-authorship of a chemistry textbook.
Richard H. Drew, PharmD, MS, FIDP
Dr. Drew currently serves as serve as an Associate Professor of Medicine at the Duke University School of Medicine and Professor of Pharmacy at Campbell University College of Pharmacy & Health Sciences. He also practices as a clinical pharmacist at Duke University Hospital on both antimicrobial stewardship and ID consult services. He served a 3-year term as SIDP President from 2006-2009 during which time he helped conduct the organization’s first strategic planning and initiate what eventually became the Antimicrobial Stewardship Certificate Program. Throughout 30+ years of clinical practice, he has played an integral role in ID education. This includes development of CustomID, a web-based tool for the dissemination of institutional-specific antimicrobial guidelines. This technology was subsequently utilized by the Netherlands for their federally-funded antimicrobial stewardship initiative, entitled SWAB. At Duke University Hospital, he co-founded a PGY2 ID residency in 1998 which had a unique emphasis on training a clinical pharmacy faculty able to practice in internal medicine and ID. For continuing education, he founded the longest standing independent CE workshop on antiinfective therapy in the state - educating general practitioners in North Carolina for 19 years. He’s the name you’ll see when you look in multimedia like UpToDate for vancomycin dosing or in peer-reviewed literature for aerosolized antifungals in lung transplant patients. With nearly 100 peer-reviewed publications and 8 book chapters, he has cemented his place in our field.
Elizabeth Hermsen, PharmD, MBA, BCPS (AQ-ID), FIDP
Dr. Hermsen is currently the Head of Global Antimicrobial Stewardship in Global Population Health at Merck & Co., Inc., and an Adjunct Associate Professor at the University of Nebraska Medical Center Colleges of Pharmacy and Medicine. When leading the antimicrobial stewardship program at The Nebraska Medical Center, she developed a publicly available antimicrobial stewardship website that most of us in this room already have saved in our bookmarks for quick reference. During her tenure with Cubist, she created the Antimicrobial Stewardship Outreach Group, which led a variety of antimicrobial stewardship-related initiatives including development of an antimicrobial stewardship research grant program (still offered today through Merck) and a research collaborative for antimicrobial stewardship programs. Throughout her career, she’s helped spearhead key scholarship in the field of antimicrobial stewardship, including a recent collaboration with the CDC and the Duke Antimicrobial Stewardship Outreach Network (DASON) to identify standardized quality outcome measures and assessment tools for hospital ASPs. She’s emerged as a strong, successful advocate for grant funding to promote awareness, research, and policy related to antimicrobial stewardship and resistance and has also helped shape legislation, such as the GAIN Act. Her contributions to SIDP are also sustained, with numerous committee appointments and a term as SIDP President from 2010-2013.
Michael E. Klepser, PharmD, FCCP, FIDPDr. Klepser is currently a Professor at Ferris State University College of Pharmacy and Adjunct Professor at the University of Nebraska Medical Center College of Pharmacy. As an ID practitioner for over 25 years, he has served in a number of roles, but none more impactful than his work in community pharmacy. He helped developed collaborative disease management programs for conditions like influenza, acute pharyngitis, and HIV screening. These programs each use CLIA-waived point-of-care tests in community pharmacies. Recognizing community pharmacists’ lack of comfort with this new service, he helped create a 20-hour certificate program on how to use CLIA-waived POCT to offer clinical services in community pharmacies. This program is now administered by the National Association of Chain Drug Stores. To date, more than 3,500 pharmacists have gone through program and several colleges of pharmacy include the training in their curricula. As member of SIDP since 1993, he has lent his expertise on numerous task forces (e.g. community antimicrobial stewardship and point-of-care testing) and has also served as past president of the organization from 2005-2008.
Joseph L. Kuti, PharmD, FIDP
Dr. Kuti currently serves as the Associate Director of Clinical and Economic Studies within the Center for Anti-Infective Research and Development at Hartford Hospital. He has demonstrated dedication to SIDP by being on the research committee for 8 years, shown leadership during his SIDP presidency from 2013-2016, and acted as our representative on the National Quality Forum which resulted in the well-known publication, “National Quality Partners Playbook: Antibiotic Stewardship in Acute Care.” With over 200 publications, including 140 original research papers and 8 book chapters, he is an invaluable asset to the field of ID, particularly regarding the clinical utility of antimicrobial dosage regimens based on pharmacokinetic and pharmacodynamics principles. In clinical practice, he has pioneered the expansion of prolonged infusions for beta-lactams as standard of care at Hartford Hospital, among other initiatives, and is now hoping to bring therapeutic drug monitoring of beta-lactams to the bedside for special patients populations.
Michael J. Rybak, PharmD, MPH, PhD, FIDP
Dr. Rybak currently serves as a Professor of Pharmacy Practice and Adjunct Professor of Medicine at Wayne State University. He has demonstrated sustained contributions to SIDP since its early days, including serving on the Board as Financial Officer/Treasurer in 1990-1992, as president from 2001-2004, and on numerous other committees and task forces. He has contributed over 350 peer-reviewed publications to the field, which garner 500 to 1500 citations annually, and is an active editor and peer-reviewer for important publications, such as Pharmacotherapy. As a recognized expert on MRSA and vancomycin, he was lead author on national vancomycin guidelines which were co-sponsored by SIDP. He has an impressive legacy of pharmacy education, including countless hours in the classroom and 44 graduates of his fellowship program. In addition, he co-founded Making a Difference in Infectious Diseases (or MAD-ID). This non-profit organization has become a valuable annual educational resource for over 20 years and more recently has trained hundreds of clinicians in antimicrobial stewardship.